Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
Most people should begin with established measures such as blood pressure, a Lipid Panel Test, blood sugar or Hemoglobin A1c Test, kidney function, smoking history, and family history
N c to thnh t ba axit amin l cysteine, glutamic, glycine v c 2 dng hot ng chnh: Glutathione tham gia vo qu trnh xy dng v sa cha m, to ra cc ha cht v protein cn thit v h tr chc nng min dch
* This product may not have the same effect on every person and may affect individual metabolisms differently
Always freeze lyophilized vials immediately upon receipt